Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letters to the Editor
  • Published:

Reply to “Histamine, cimetidine and colorectal cancer”

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Morris, D.L. & Adams, W.J. Cimetidine and colorectal cancer — old drug, new use? Nature Med. 1, 1243–1244 1995

    Article  CAS  Google Scholar 

  2. Svendsen, L.B. et al. Cimetidine as an adjuvant treatment in colorectal cancer: A double-blind randomized pilot study. Dis. Colon Rectum. 38, 514–518 1994.

    Article  Google Scholar 

  3. Links, M. et al. A randomized trial of cimetidine with 5-fluorouracil and folinic acid in metastatic colorectal cancer. Eur. J. Surg. Oncol. 21, 523–525 1995

    Article  CAS  Google Scholar 

  4. Rovere, F., Broccio, G., Granata, A. & Fimiani, V. In vivo experimental demonstration that hyper-histamism counteracts tumor growth. Oncol. Reports 1, 175–177 1994

    Google Scholar 

  5. Hellstrand, K., Asea, A. & Hermodsson, S. Histaminergic regulation of natural killer cell function: Role of monocyte-derived reactive oxygen metabolites. J.Immunol. 153, 4940–4947 1994

    CAS  PubMed  Google Scholar 

  6. Hellstrand, K. et al. Regulation of the NK cell response to interferon-α by biogenic amines. J.Interferon Res. 12, 199–204 1992.

    Article  CAS  Google Scholar 

  7. Gilbert, H.S., Warner, R.R.P. & Wasserman, L.R. A study of histamine in myeloproliferative disease. Blood. 28, 795–805 1966

    CAS  PubMed  Google Scholar 

  8. Asea, A. Role of histamine in the regulation of natural killer cells, thesis, University of Goteborg 1995

  9. Hellstrand, K. et al. Histamine in immunotherapy of advanced melanoma. Cancer Immunol. Immunother. 39, 416–419 1994

    Article  CAS  Google Scholar 

  10. Brune, M. & Hellstrand, K. Remission maintenance therapy with histamine and interleukin-2 in acute myelogenous leukemia. Br. J. Haematol. (in the press).

  11. Osband, M.E. et al. Successful immunotherapy with cimetidine in mice. Lancet. i, 636 1981

  12. Mandanas, R., Schultz, S., Scullin, D. & Einhorn, L.H. Phase II trial of cimetidine in metastatic melanoma: A Hoosier Oncology Group trial. Am. J. Clin. Oncol. 14, 397–399 1991.

    Article  CAS  Google Scholar 

  13. Creagan, E.T. et al. Phase II study of recombinant leukocyte A interferon (IFN-RA) plus cimetidine in disseminated malignant melanoma. J.Clin. Oncol. 3, 977–981 1985

    Article  CAS  Google Scholar 

  14. Jones, C. et al. Post marketing surveillance of the safety of cimetidine: 10 year mortality report. Gut 33, 1280–1284 1992

    Article  Google Scholar 

  15. Kikucki, Y. et al. Augmented natural killer activity in ovarian cancer of patients treated with cimetidine. Eur. J. Cancer Clin. Oncol. 22, 1037–1043 1986

    Article  Google Scholar 

  16. Adams, W. et al. cimetidine inhibts in vivo growth of human colon cancer and reverses histamine in vitro and in vivo growth Gut. 39, 1632–1636 1994

    Article  Google Scholar 

  17. Adams, W. & Morris, D.L. Short course cimetidine and survival with colorectal cancer. Lancet 344, 8939–8940, 1768–1769 1994.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

L.Morris, D. Reply to “Histamine, cimetidine and colorectal cancer”. Nat Med 2, 364–365 (1996). https://doi.org/10.1038/nm0496-364b

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm0496-364b

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing